IMP3 and bladder transitional cell carcinoma: A recent study demonstrated that IMP3, a member of the insulin-like growth factor II messenger RNA binding protein (IMP) family, was significantly upregulated in muscle-invasive BLCA compared to non-muscular invasive tissues and could serve as an independent prognosis predictor for BLCA patients [9].